Skip to content

Luohe Acute Coronary Syndrome Cohort Study

Luohe Acute Coronary Syndrome Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127267
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome (Unstable angina, Non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction)

Interventions

Luohe Acute Coronary Syndrome Cohort:None

Sponsors

Luohe Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with acute coronary syndrome (ACS: UA/NSTEMI/STEMI) via standardized examinations, who receive treatment, follow-up or management at the Chest Pain Center network hospitals (including the leading hospital) of Luohe Central Hospital Medical Group. 2.Available complete clinical data and key medical records, including laboratory tests, electrocardiogram, echocardiography, coronary angiography and interventional records, to support outcome follow-up and risk assessment. 3.Participants are willing and able to complete 30-year annual follow-up via telephone or outpatient visits, and provide valid contact information for themselves and at least one relative.

Exclusion criteria

Exclusion criteria: 1.Critically unstable acute conditions with hemodynamic instability due to cardiogenic shock, refractory malignant arrhythmia, end-stage heart failure or other causes, as judged by the research team to be ineligible for baseline assessment and follow-up; 2.Confirmed malignant tumors or other severe non-cardiovascular diseases such as severe trauma and burns, with a life expectancy of less than 1 year or inability to complete follow-up; 3.Severe mental disorders, disturbance of consciousness or cognitive impairment that prevents participation in questionnaires and follow-up, with no eligible legal representative or caregiver available; 4.No valid contact information or confirmed refusal/inability to receive long-term follow-up; 5.Pregnant women (confirmed or clinically suspected pregnancy);

Design outcomes

Primary

MeasureTime frame
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), including death, myocardial infarction, stroke, hospitalization for heart failure, and unplanned repeat revascularization (PCI/CABG);

Secondary

MeasureTime frame
Cardiac death;

Countries

China

Contacts

Public ContactWang Haoran

Luohe Central Hospital

18339561986@163.com+86 395 3330559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026